These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6098743

  • 1. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infections associated with hematological disorders].
    Uchida T, Matsuda S, Kimura H, Satoh T, Ishibashi T, Kokubun K, Umezu H, Horikawa A, Saitoh T, Sakauchi Y.
    Jpn J Antibiot; 1984 Dec; 37(12):2506-18. PubMed ID: 6098743
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infection associated with hematological disorders].
    Kawamura S, Sakata Y, Chiba Y, Yoshida Y, Kanazawa T, Kawazu S, Tsuge M, Tanabe K, Nara H, Aizawa M.
    Jpn J Antibiot; 1986 May; 39(5):1250-8. PubMed ID: 3463775
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
    Kozuru M, Kurata T, Uike N, Niho Y, Shibuya T, Otsuka T, Yamano Y, Hirota Y, Nishimura J, Katsuno M.
    Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
    Minami Y, Kanda S, Matsuo R, Sakai H, Kamemoto H, Hisamatsu A, Maruta N, Johdai A, Shimomae H, Watanabe Y.
    Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of cefotiam in internal medicine].
    Kawamura S, Sakata Y, Chiba Y, Yoshida Y, Aizawa M, Nara H, Yanagiya S, Fukushi K, Ohmi T, Okamoto K, Komatsu Y, Haneda Y, Tanabe K, Segawa M, Yamagata A, Kawatsu S.
    Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
    Bechard DL, Hawkins SH, Sutherland SC.
    Am J Med; 1984 Dec 21; 77(6A):13-6. PubMed ID: 6097117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of cefmenoxime and cefsulodin in chronic complicated urinary tract infections].
    Shiraiwa Y, Yamaguchi O, Ito K, Kuma Y, Hozumi S, Kumakawa K, Ishiwata H, Arai M, Hirai T, Kumagai I.
    Jpn J Antibiot; 1986 Oct 21; 39(10):2661-74. PubMed ID: 3468273
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
    Tsuchida S, Sasaki S, Takada H, Miyagata S, Sato S, Shimizu S, Sakamoto F, Kizu N.
    Hinyokika Kiyo; 1985 Feb 21; 31(2):365-74. PubMed ID: 3859998
    [Abstract] [Full Text] [Related]

  • 17. [Laboratory and clinical studies on cefmenoxime in respiratory tract infections].
    Ida S, Nishioka K, Takishima T, Kudo K, Sakamoto M, Inoue C, Shimanuki K, Fujimoto R, Miura M, Takahashi M.
    Jpn J Antibiot; 1986 Nov 21; 39(11):2869-76. PubMed ID: 3469421
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.